/PRNewswire/ Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that.
The presence of Hashimoto thyroiditis lowers the risk of recurrence of BRAF mutation-positive or mutation-negative differentiated thyroid cancer. BRAF V600E mutation is a negative prognostic factor.